NHS plans to distribute the weight-loss drug Mounjaro "are unambitious" and will reach a "woefully small number of people", MPs have warned.
A report by the Commons Health and Social Care Committee found that only about 6 per cent of eligible patients will get or currently receive Mounjaro (a GLP-1 weight loss drug) through the NHS across its initial three years, with millions more turning instead to private firms.
